These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 2255067

  • 1. [Successful therapy of Ph1 positive chronic myelocytic leukemia with oral form of etoposide].
    Aihara M, Sasaki Y, Yoshida Y.
    Rinsho Ketsueki; 1990 Oct; 31(10):1745-9. PubMed ID: 2255067
    [Abstract] [Full Text] [Related]

  • 2. [Successful low-dose etoposide therapy for a case of myelofibrosis with chronic myelogenous leukemia megakaryocytic predominance type].
    Katayama T, Masuoka H, Yoshida M, Watanabe R, Nishiwaki K, Shimada T, Kaito K, Ochiai S, Kobayashi M, Sakai O.
    Rinsho Ketsueki; 1992 Apr; 33(4):488-93. PubMed ID: 1602613
    [Abstract] [Full Text] [Related]

  • 3. [Partial and complete disappearance of Ph1 chromosome in two patients with chronic myelogenous leukemia after conventional chemotherapy].
    Kitabayashi A, Miura I, Ito T, Takahashi M, Chubachi A, Niitsu H, Mamiya S, Miura AB.
    Rinsho Ketsueki; 1993 Jun; 34(6):733-7. PubMed ID: 8366576
    [Abstract] [Full Text] [Related]

  • 4. [Discrepancy in karyotypes between peripheral blood and bone marrow during blastic crisis in chronic myelocytic leukemia].
    Maeda T, Ashie T, Kikuiri K, Ishiyama N, Takakura M.
    Rinsho Ketsueki; 1989 Jul; 30(7):1032-6. PubMed ID: 2810787
    [Abstract] [Full Text] [Related]

  • 5. [Intermittent administration of natural interferon-alpha for over 5 years induced complete suppression of Philadelphia chromosome in a patient with myelogenous leukemia].
    Koyama S, Aoki S, Furukawa T, Takahashi M, Kishi K, Koike T, Moriyama Y, Hattori A, Shibata A.
    Rinsho Ketsueki; 1991 Dec; 32(12):1577-9. PubMed ID: 1779460
    [Abstract] [Full Text] [Related]

  • 6. [Extramedullary blast crisis of mixed precursor T lymphoblastic and myeloblastic features in a patient with chronic myelogenous leukemia successfully treated with low-dose oral etoposide].
    Konaka Y, Namiuchi S.
    Rinsho Ketsueki; 1993 Dec; 34(12):1556-61. PubMed ID: 8295329
    [Abstract] [Full Text] [Related]

  • 7. [Chronic myelomonocytic leukemia with good response to low-dose etoposide].
    Ando S, Ando S, Otani N, Kanbe T.
    Rinsho Ketsueki; 1992 Dec; 33(12):1890-4. PubMed ID: 1479704
    [Abstract] [Full Text] [Related]

  • 8. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Dec; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 9. [BCR rearrangement and cytogenetic findings in Philadelphia-positive chronic myelocytic leukemia in children].
    Shikano T, Kikuta H, Ishikawa Y, Naito H, Ohkawa M, Nakadate N, Hatae Y, Takeda T.
    Rinsho Ketsueki; 1989 Jan; 30(1):29-35. PubMed ID: 2716196
    [Abstract] [Full Text] [Related]

  • 10. [Appearance of chromosomally normal hemopoiesis during busulfan-induced remission in a case of Ph1 positive chronic myelogenous leukemia].
    Takahira H, Ideguchi H, Hirata J, Nishimura J, Nawata H, Shimizu S.
    Rinsho Ketsueki; 1989 Feb; 30(2):251-5. PubMed ID: 2746880
    [Abstract] [Full Text] [Related]

  • 11. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F.
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [Abstract] [Full Text] [Related]

  • 12. [Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma].
    Hasegawa A, Ninomiya H, Yanagisawa K, Takada K, Hasegawa H, Hato T, Yasukawa M, Fujita S.
    Rinsho Ketsueki; 1996 Sep; 37(9):853-7. PubMed ID: 8914475
    [Abstract] [Full Text] [Related]

  • 13. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
    O'Brien S, Giles F, Talpaz M, Cortes J, Rios MB, Shan J, Thomas D, Andreeff M, Kornblau S, Faderl S, Garcia-Manero G, White K, Mallard S, Freireich E, Kantarjian HM.
    Cancer; 2003 Sep 01; 98(5):888-93. PubMed ID: 12942553
    [Abstract] [Full Text] [Related]

  • 14. [Successful chronic daily administration of oral etoposide for a case of adult T cell leukemia].
    Matsuoka H, Toyama T, Horinouchi M, Maeda K, Suzuki M, Kubuki Y, Komura K, Ishikawa T, Uno H, Tsubouchi H.
    Gan To Kagaku Ryoho; 1993 Aug 01; 20(10):1387-90. PubMed ID: 8346938
    [Abstract] [Full Text] [Related]

  • 15. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
    Kuyama J, Take H.
    Rinsho Ketsueki; 1995 Dec 01; 36(12):1353-8. PubMed ID: 8587171
    [Abstract] [Full Text] [Related]

  • 16. [Natural interferon alpha for chronic myelogenous leukemia in the chronic phase: hematologic, cytogenetic and molecular response].
    Takeuchi J, Kawamura M, Sawada U, Ohshima T, Horie T, Horikoshi A, Abe T.
    Rinsho Ketsueki; 1995 Oct 01; 36(10):1149-56. PubMed ID: 8531323
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.
    Kantarjian H, O'Brien S, Cortes J, Shan J, Giles F, Garcia-Manero G, Verstovsek S, Faderl S, Rios MB, Talpaz M.
    Cancer; 2003 Oct 01; 98(7):1430-7. PubMed ID: 14508830
    [Abstract] [Full Text] [Related]

  • 18. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Cortes J, Talpaz M, O'Brien S, Giles F, Beth Rios M, Shan J, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Kantarjian H.
    Cancer; 2003 Sep 15; 98(6):1105-13. PubMed ID: 12973833
    [Abstract] [Full Text] [Related]

  • 19. High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.
    Kantarjian HM, Talpaz M, Andersson B, Khouri I, Giralt S, Rios MB, Champlin R, Hester J, Deisseroth AB.
    Bone Marrow Transplant; 1994 Jul 15; 14(1):57-61. PubMed ID: 7951120
    [Abstract] [Full Text] [Related]

  • 20. [Late appearance of Philadelphia chromosome with bcr gene rearrangement in an acute myelocytic leukemia patient].
    Takechi M, Tanaka K, Sigeta C, Oguma N, Kamada N, Kyo T, Dohi H.
    Rinsho Ketsueki; 1989 Dec 15; 30(12):2225-9. PubMed ID: 2695664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.